JBHT
63
11
BSX
54
-5
CHRW
71
-5
INTU
58
-7
BLK
58
-2
EOG
54
9
UNH
29
-7
ROK
60
-2
RSG
47
-7
HST
52
10
LMT
57
7
DVA
47
-2
DRI
53
3
SO
50
-3
MA
46
-4
AIZ
50
-2
BAX
41
-3
K
60
6
FAST
34
-12
RL
76
-7
JBHT
63
11
BSX
54
-5
CHRW
71
-5
INTU
58
-7
BLK
58
-2
EOG
54
9
UNH
29
-7
ROK
60
-2
RSG
47
-7
HST
52
10
LMT
57
7
DVA
47
-2
DRI
53
3
SO
50
-3
MA
46
-4
AIZ
50
-2
BAX
41
-3
K
60
6
FAST
34
-12
RL
76
-7
Financhill
Back

Bitfarms Ltd. (Canada) Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
24

BITF
Bitfarms Ltd. (Canada)

Last Price:
$2.90
Seasonality Move:
113.53%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
24
Bitfarms Ltd. (Canada) (BITF) is a Sell

Is Bitfarms Ltd. (Canada) a Buy, Sell or Hold?

  • The current Bitfarms Ltd. (Canada) [BITF] share price is $2.91. The Score for BITF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • BITF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BITF Stock Price Chart

What is Bitfarms Ltd. (Canada)'s stock price today?

  • The Bitfarms Ltd. (Canada) share price today is $2.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BITF is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

BITF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 43.76 Sell
Chaikin Money Flow: -5641371 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.65 - 3.61) Sell
Bollinger Bands (100): (1.36 - 3.94) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

BITF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.13 Sell
20-day SMA: 2.95 Sell
50-day SMA: 3.67 Sell
200-day SMA: 1.81 Buy
8-day EMA: 3.01 Sell
20-day EMA: 3.12 Sell
50-day EMA: 3.19 Sell
200-day EMA: 2.31 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Bitfarms Ltd. (Canada) Earnings Growth & BITF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.93 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Bitfarms Ltd. (Canada) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):